{"id":"W4405616616","doi":"10.3802/jgo.2025.36.e51","title":"Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)","year":2024,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Research Foundation of Korea; Medical Research Council; PharmaMar; Eisai; Amgen; National University of Singapore; National Research Foundation; Chugai Pharmaceutical; Seagen; MacroGenics; Sierra Oncology; Incyte; BeiGene; Clovis Oncology; AstraZeneca; Novocure; Ministry of Science and ICT, South Korea; Kimberly-Clark; Regeneron Pharmaceuticals; Mersana Therapeutics; National Medical Research Council; Karyopharm Therapeutics; Sanofi; GlaxoSmithKline","keywords":"Medicine; Bevacizumab; Chemotherapy; Oncology; Internal medicine; Carcinoma; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003397797,0.00252955,0.003743025,0.0006540655,0.0004209183,0.001202059,0.001528193,0.00191399,0.009174039],"category_scores_gemma":[0.002768217,0.001010823,0.001746619,0.0006612272,0.002055266,0.001493425,0.0007275369,0.003279717,0.001355189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001329637,"about_ca_system_score_gemma":0.002437457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001314462,"about_ca_topic_score_gemma":0.00305557,"domain_scores_codex":[0.9987645,0.000740657,0.00005784888,0.0001869286,0.00008405804,0.0001659955],"domain_scores_gemma":[0.997673,0.0005751063,0.000490309,0.0002053607,0.0001118596,0.0009443322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.973323,0.01498949,0.000641902,0.000200834,0.0003662316,0.00003059269,0.00003295541,0.0003467526,0.002179118,0.00007940159,0.0006384501,0.007171178],"study_design_scores_gemma":[0.9120471,0.08566422,0.001006653,0.000009282185,0.0001425578,0.00002532651,0.00001294171,0.0003243123,0.0002809814,0.0001038712,0.0003741868,0.000008657064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980262,0.001663373,0.0009379974,0.0007053602,0.0005081694,0.01194436,0.001671428,0.0001583231,0.002149009],"genre_scores_gemma":[0.9653738,0.001604301,0.004061142,0.001708203,0.0006425812,0.01818276,0.003032895,0.00006559661,0.005328646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009174039,"threshold_uncertainty_score":0.03069025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03196311436663559,"score_gpt":0.3535288015074919,"score_spread":0.3215656871408563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}